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ABSTRACT: Preprotein translocation in Escherichia coli is mediated by translocase, a multimeric membrane
protein complex with SecA as the peripheral ATPase and SecYEG as the translocation pore. Unique
cysteines were introduced into transmembrane segment (TMS) 2 of SecY and TMS 3 of SecE to probe
possible sites of interaction between the integral membrane subunits. The SecY and SecE single-Cys
mutants were cloned individually and in pairs into a secYEG expression vector and functionally
overexpressed. Oxidation of the single-Cys pairs revealed periodic contacts between SecY and SecE that
are confined to a specific R-helical face of TMS 2 and 3, respectively. A Cys at the opposite R-helical
face of TMS 3 of SecE was found to interact with a neighboring SecE molecule. Formation of this SecE
dimer did not affect the high-affinity binding of SecA to SecYEG and ATP hydrolysis, but blocked
preprotein translocation and thus uncouples the SecA ATPase activity from translocation. Conditions that
prevent membrane deinsertion of SecA markedly stimulated the interhelical contact between the SecE
molecules. The latter demonstrates a SecA-mediated modulation of the protein translocation channel that
is sensed by SecE.
In the well-studied general secretory pathway of Escheri-
chia coli, preproteins are targeted to the cytoplasmic
membrane either as ribosome-bound nascent chains by a
signal recognition particle and FtsY (1, 2) or as completely
synthesized polypeptides. Proteins which are secreted through
the post-translational pathway can be kept translocation
competent by the export-dedicated molecular chaperone SecB
(3, 4). Both targeting routes converge at a membrane protein
complex termed translocase (5). Translocase consists of a
peripherally membrane-associated ATPase, SecA (6), and
the SecYEG heterotrimeric integral membrane protein com-
plex (7). The dimeric SecA is activated for SecB recognition
when bound to the membrane at SecYEG (4, 8). SecB
donates the preprotein to SecA, and is released into the
cytosol upon the exchange of SecA-bound ADP1 for ATP
(9). The latter reaction elicits a conformational change that
permits SecA domains to insert into the membrane with the
concomitant insertion of the preprotein (10). The inserted
preprotein is released from its association with SecA upon
hydrolysis of ATP (11), and SecA reverts to its membrane
surface-bound state. SecA may rebind the partially translo-
cated preprotein, and complete translocation may occur via
multiple cycles of ATP binding and hydrolysis (11-13). In
the absence of SecA association, translocation may also be
driven by the proton motive force (11, 14).
The translocase holoenzyme is formed by only SecA,
SecY, and SecE (15, 16). However, SecG copurifies with
the SecYE complex (7, 17), and its presence markedly
enhances the efficiency of in vitro preprotein translocation
(18). SecD, SecF, and YajC are integral membrane proteins
that assemble into a complex that interacts with SecYEG
(16). They may add to the fidelity of the translocation
reaction as overexpression of the SecDFYajC complex
stabilizes SecA in the membrane-inserted state (19, 20). SecD
and SecF are not essential for preprotein translocation, but
in their absence, cells are no longer able to sustain a proton
motive force and are cold sensitive for growth (21, 22). In
vitro experiments have demonstrated that the SecYEG
complex suffices to support efficient SecA-dependent pre-
protein translocation (7, 17, 23).
The SecYEG complex shares functional and structural
characteristics with the Sec61p protein-conducting channel
of the eukaryotic endoplasmic reticulum (24, 25). High-
resolution electron microscopy images of the mammalian and
yeast Sec61p complex show ring-like oligomeric structures,
which are formed after interaction with the ribosome (26,
27). These structures seem to consist of two to four Sec61p
trimers with a central pore. Recently, it has been shown that
the bacterial SecYE of Bacillus subtilis exhibits quasi-
pentagonal structures, which resemble the Sec61p system
(28). These structures are thought to consist of an oligomeric
assembly of three SecYE subunits.
Both biochemical and genetic data have demonstrated that
SecY and SecE interact, but the exact sites of interaction
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have not been identified. The synthetic lethality of various
combinations of SecY (prlA) and SecE (prlG) signal
sequence suppressor mutants suggests an interaction between
the periplasmic loop 1 (P1) of SecY and P2 of SecE, and
indicate that transmembrane segment (TMS) 7 and TMS 10
of SecY are close to TMS 3 of SecE (29, 30). Cytoplasmic
domain 4 (C4) of SecY has been suggested to interact with
C2 of SecE (31, 32). To obtain detailed insight into the
molecular architecture of the SecYEG complex, we have
carried out cysteine scanning mutagenesis. This is a powerful
technique that has been used to reveal the helix packing and
structure-function relationships in polytopic membrane
proteins (33, 34). On the basis of the interaction between
P1 of SecY and P2 of SecE and the observation that TMS 1
and 2 of SecE are not essential for its function (35), we have
selected TMS 2 of SecY and TMS 3 of SecE to introduce
single cysteine residues. By combining single-Cys mutants,
we were able to directly demonstrate specific contacts
between these TMSs. In addition, a specific helical face of
TMS 3 of SecE interacts with a neighboring SecE molecule.
The latter interaction is stimulated when SecA membrane
deinsertion in the presence of a preprotein is blocked, and
suggests an oligomeric structure of the SecYEG complex
where at least two SecE subunits are in close proximity.
EXPERIMENTAL PROCEDURES
Materials. E. coli SecA (6), SecB (36), and proOmpA (37)
were purified as described previously. ProOmpA was iodi-
nated as described for preAmyL (38), and stored frozen in
6 M urea and 50 mM Tris-HCl (pH 7.8). Wild-type and
mutant SecYEG complexes were purified as described
previously and reconstituted into liposomes of E. coli
phospholipid by detergent dilution (17). Polyclonal antibodies
(pAb) raised against purified His-tagged SecY and SecE, and
against a synthetic peptide corresponding to a SecG domain,
were obtained as described previously (17). A stock solution
of 80 mM Cu2+(phenanthroline)3 complex was prepared by
mixing 120 íL of 0.36 M 1,10-phenanthroline in 50%
ethanol with 60 íL of 0.24 M CuSO4.
Bacterial Strains and Growth Conditions. For all experi-
ments, E. coli strain SF100 (39) was used. Cells were grown
aerobically at 37 °C on L-broth in the presence of 100 íg/
mL ampicillin in a shaking incubator until the end of the
logarithmic phase. For the induction of plasmid-encoded
genes under the control of an IPTG inducible promoter,
exponentially growing cultures were supplemented with 0.5
mM isopropyl â-D-thiogalactopyranoside (IPTG) at an OD660
of 0.6, and growth was continued for an additional 2 h.
Plasmid Construction. The vector pET349 (SechYnEG+)
allows the overproduction of His-tagged SecYEG under
control of the IPTG-inducible trc promoter (17, 40). To
facilitate cloning and the introduction of unique Cys muta-
tions in SecY and SecE, the HincII site in SecE was removed
from pET349, resulting in pET610 (Table 1). To construct
a Cys-less SecY, Cys329 and Cys385 were substituted for
serine residues in the secY gene of pET605, resulting in
pET608 and pET609, respectively. These mutations were
transferred to pET610, yielding pET607 which expresses the
Cys-less SecYEG complex with a His tag at the amino
terminus of SecY. pET607 was used to reintroduce single
Cys mutations into SecY and SecE. To facilitate the
screening for correct mutants, silent modifications in restric-
tion sites were made. Insertion of a single Cys in TMS 3 of
SecE was accompanied by the deletion of the ClaI site
between SecY and SecE (ATCGAT f ATCGAC), and
insertion of the single Cys in TMS 2 of SecY was
accompanied with the deletion of the StuI site in SecY
Q146Q (CAA f CAG). Single-Cys mutants of TMS 2 of
SecY were combined with the Cys mutants in TMS 3 of
SecE by exchange of the SecYE EcoRI-BamHI fragment.
Overexpression of single-Cys SecE mutants was achieved
by cloning the appropriate NcoI-BamHI SecE fragments in
pET324. All mutageneses were carried out via two-step PCR,
and constructs were confirmed by sequence analysis on a
Vistra DNA sequencer 725 using the automated ¢taq
sequencing kit (Amersham, Buckinghamshire, U.K.). All
other DNA techniques followed standard procedures.
Table 1: Plasmids Used in This Studya
plasmid relevant characteristics mutations ref
pET349 N-terminally His-tagged SecYEG 17
pET608 PET610 with SecY(C385S) C385S (TGC f AGC) this study
pET609 PET610 with SecY(C329C) C329S (TGT f AGT) this study
pET607 Cys-less SecYEG in pET610 this study
pET610 pET349 with ¢HincII in secE L60C (CTG f CTC) this study
pET626 SecE(S105C) in pET607 S105C (TCA f TGT)/¢ClaI (ATCGAT f ATCGAC) this study
pET627 SecE(L106C) in pET607 L106C (CTG f TGT)/¢ClaI (ATCGAT f ATCGAC) this study
pET628 SecE(I107C) in pET607 I107C (ATC f TGC)/¢ClaI (ATCGAT f ATCGAC) this study
pET629 SecE(L108C) in pET607 L108C (CTG f TGT)/¢ClaI (ATCGAT f ATCGAC) this study
pET630 SecE(W109C) in pET607 W109C (TGT f TGT)/¢ClaI (ATCGAT f ATCGAC) this study
pET636 SecY(F78C) in pET607 F78C (TTT f TGT)/Q146Q (CAA f CAG) this study
PET637 SecY(A79C) in pET607 A79C (GCT f TGT)/Q146Q (CAA f CAG) this study
PET638 SecY(L80C) in pET607 L80C (CTG f TGT)/Q146Q (CAA f CAG) this study
PET639 SecY(G81C) in pET607 G81C (GGG f TGT)/Q146Q (CAA f CAG) this study
PET640 SecY(I82C) in pET607 I82C (ATC f TGC)/Q146Q (CAA f CAG) this study
pET301 SecE in pET324 this study
pET1602 SecE(S105C) in pET324 this study
pET1603 SecE (L106C) in pET324 this study
pET1604 SecE(I107C) in pET324 this study
pET1605 SecE(L108C) in pET324 this study
pET1606 SecE(W109C) in pET324 this study
a Double-Cys mutants are not described in the table. Their names are derived from combinations of the names of the single-Cys mutants. pET636/
623, for example, overexpresses SecYEG with the mutations F78C and L107C in SechYn and SecE, respectively.
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Isolation of Inner Membrane Vesicles. A rapid membrane
isolation procedure was developed to facilitate the analysis
of a large number of mutant SecYEG complexes. Liquid
nitrogen-frozen cells were quickly thawed at 37 °C, and
diluted with an equal volume of 20% glycerol and 50 mM
Tris-HCl (pH 8.0) (buffer A). The suspension was subjected
to French press treatment (four times at 8000 psi), diluted
with an equal volume of buffer A, and cleared from debris
by centrifugation (4000g for 10 min). Membranes were
collected from the supernatant by centrifugation (40000g for
90 min), resuspended in buffer A, and loaded onto a four-
step sucrose gradient that consisted of 0.3, 0.9, 0.9, and 0.3
mL of a 36, 45, 51, and 54% (w/v) sucrose solution in 50
mM Tris-HCl (pH 8.0), respectively. Inner membranes
vesicles (IMVs) were separated from outer membranes
through velocity centrifugation (250 000 rpm for 30 min,
Beckmann TLA 100.4 rotor), collected from the gradient,
and diluted with 5 volumes of buffer A. Purified IMVs were
recollected by centrifugation (40000g for 90 min), resus-
pended in buffer A at a concentration of 10 mg/mL, and
stored in liquid nitrogen.
Cross-Linking. For assays of disulfide bridge formation,
vesicles were incubated for 30 min on ice in the presence of
1 mM Cu2+(phenanthroline)3 (oxidized) or, as a control, with
10 mM dithiothreitol (DTT) (reduced). Oxidation was
terminated with 25 mM neocuproine to protect the unreacted
thiols, and the samples were analyzed on 10 or 15% SDS-
PAGE, followed by Western blotting and immunostaining
with R-SecY, R-SecE, and R-SecG pAbs. The extent of
SecE(L106C) cross-linking after preincubation was measured
with vesicles that had been reduced with 5 mM DTT before
dilution in the translocation reaction mixture. Reaction
mixtures were then incubated as indicated, placed on ice,
and oxidized with 1 mM Cu2+(phenanthroline)3 as described.
Translocation Assays. Translocation assays were per-
formed in 50 íL of buffer B consisting of 50 mM HEPES/
KOH (pH 7.5), 30 mM KCl, 5 mM Mg(Ac)2, and 0.5 mg/
mL bovine serum albumin (BSA). Creatine phosphate (10
mM) and creatine kinase (0.5 íg) were added as an ATP-
regenerating system. Reaction mixtures furthermore consisted
of 1.6 íg of SecB, 1 íg of SecA, 1 íL of 125I-labeled
denatured proOmpA [1 mg/mL in 6 M urea and 50 mM Tris-
HCl (pH 7.5)], and 10 íg of SecYEG+ IMVs or 6.5 íg of
SecYEG proteoliposomes that had been preincubated for 30
min at 0 °C in the presence of 5 mM DTT or 1 mM Cu2+-
(phenanthroline)3. Reaction mixtures were energized with 2
mM ATP and kept at 37 °C, and at various time points,
samples were taken, chilled on ice, and treated with pro-
teinase K (0.1 mg/mL) for 15 min. Reaction mixtures were
then precipitated (20000g for 10 min) with ice-cold trichloric
acid (10% w/v), washed with acetone, and analyzed by
SDS-PAGE on 12% PAA gels. For SecA membrane
insertion assays, reactions were performed with 0.2 íg of
125I-labeled SecA and unlabeled proOmpA.
Other Analytical Techniques. Binding assays were per-
formed as described previously (41). Translocation ATPase
activity of urea-treated IMVs or SecYEG proteoliposomes
was measured with proOmpA as the substrate (42). SecA
membrane insertion assays in which [125I]SecA was used
were performed as described previously (10). Protein con-
centrations were determined by the method of Lowry (43)
in the presence of SDS using BSA as a standard. Semidry
Western blotting (Trans-Blot apparatus, Bio-Rad, Hercules,
CA) was performed at 4 mA/cm2 of blotting membrane
(PVDF, Boehringer) for 45 min, using a buffer consisting
of 48 mM Tris, 30 mM glycine, and 20% (v/v) methanol,
with or without 0.1% (w/v) SDS.
RESULTS
Construction and ActiVity of Single-Cysteine Mutants of
SecY and SecE. To investigate the interaction between SecY
TMS 2 and SecE TMS 3, we have employed a cysteine
FIGURE 1: Topology model of SecY and SecE. The endogenous cysteine residues that were replaced with serine residues to create the
Cys-less SecY are denoted as black diamonds. Single Cys mutations in TMS 2 of SecY and TMS 3 of SecE are denoted as black circles.
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scanning mutagenesis approach. The E. coli SecY contains
two endogenous cysteines, i.e., Cys329 and Cys385 located
in TMS 8 and 9, respectively (Figure 1). SecE and SecG
are devoid of Cys residues. A Cys-less SecY was constructed
by replacing Cys329 and Cys385 with serine residues using
site-directed mutagenesis. The Cys-less SecY was subse-
quently used to introduce five (F78C, A79C, L80C, G81C,
and I82C) unique Cys residues into a consecutive stretch of
TMS 2 to cover at least one turn of this putative R-helical
segment. Likewise, five (S105C, L106C, I107C, L108C, and
W109C) unique Cys residues were introduced into TMS 3
of SecE. These mutations are predicted to be located in the
part of the TMS close to the periplasmic face of the
membrane (Figure 1; 44, 45). The single-Cys SecY and SecE
mutants were cloned either individually or as pairs into the
secYEG expression vector under control of the trc promotor
with an amino-terminal His tag on SecY (40) (see Table 1).
Inner membrane vesicles (IMVs) derived from cells that
express the SecYEG complex were checked by SDS-PAGE,
CBB staining, and Western blotting using pAbs against SecY,
SecE, and SecG. With each of the constructs, SecY, SecE,
and SecG were overexpressed to the same extent as the wild-
type SecYEG complex. This is shown in Figure 2A for the
Cys-less SecYEG and the complexes that bear the single-
Cys SecE mutations, but identical results were obtained for
the individual SecY mutants, and the SecE-SecY mutant
combinations. Since SecY is only stable when overexpressed
together with SecE (46), it appears that with each of the Cys
mutants a stable SecY-SecE interaction is achieved. IMVs
were analyzed for the in vitro translocation of 125I-labeled
proOmpA (Figure 2B) and for the SecA translocation
ATPase activity in the presence of proOmpA (Figure 2C).
These assays were performed in the presence of DTT to
prevent possible oxidation of the Cys residues. In all cases,
the activities of the mutant SecYEG complexes were similar
to that of the wild type. IMVs were also tested for the
translocation of [125I]¢8proOmpA, a proOmpA derivative
with a defective signal sequence due to the deletion of Ile8.
In contrast to IMVs of the prlA4 strain (41) that expresses
the PrlA4 SecY at wild-type levels, none of the overex-
pressed mutants was able to translocate ¢8proOmpA (data
not shown). This suggests that the mutagenesis has not
yielded any strong prlA or prlG mutants. In summary, the
Cys-less SecYEG, the single-Cys mutants of SecY and SecE,
and the pairs of SecY and SecE mutants are normally
overexpressed and are functionally active.
TMS 2 of SecY and TMS 3 of SecE Are Interacting
Transmembrane Segments. To identify interhelical contacts
between SecY and SecE, the membranes containing the
SecYEG complex with the pairs of single-Cys mutants of
SecY and SecE were oxidized with 1 mM Cu2+(phenan-
throline)3. The reaction was then quenched with 10 mM
neocuproine, and protein profiles were analyzed by SDS-
PAGE in the absence of reducing agents, Western blotting,
and immunodetection using pAbs directed against SecY and
SecE. Out of a total of 25 Cys pairs, only the combinations
of SecY(F78C) with SecE(L108C), SecY(A79C) with SecE-
(L108C), and SecY(I82C) with SecE(S105C) yielded a
slowly migrating protein band after oxidation that reacted
with both pAbs directed against SecY and SecE (Figure 3).
This putative cross-linked product of SecY and SecE
exhibited an apparent molecular mass of 50 kDa on SDS-
PAGE, and its formation was reversed by the addition of
DTT (data not shown). The cross-linked product was not
observed in membranes containing the Cys-less SecYEG (see
Figure 4) or single-Cys mutants of SecY or SecE. Modeling
of TMS 2 of SecY and TMS 3 of SecE reveals that all
detected cross-links are confined to a distinct helical face,
and that the interaction reappears after a single turn of both
helical segments (Figure 9). The latter periodicity indicates
that TMS 2 of SecY and TMS 3 of SecE are indeed R-helical
FIGURE 2: Overexpression of SecY, SecE, and SecG proteins in
E. coli SF100 cells. (A) Coomassie brilliant blue-stained SDS-
PAGE of IMVs derived from SF100 cells harboring plasmids
pET324 (control, lane 1), pET610 (SecYEG, lane 2), pET607 (Cys-
less SecYEG, lane 3), pET626 [SecYE(S105C)G, lane 4], pET627
[SecYE(L106C)G, lane 5], pET628 [SecYE(I107C)G, lane 6],
pET629 [SecYE(L108C)G, lane 7], and pET630 [SecYE(W109C)G,
lane 8]. The positions of the molecular mass markers are indicated.
(B) Translocation of [125I]proOmpA into IMVs. Translocation
reactions were performed for 10 min in the presence of SecA and
ATP. The positions of proOmpA and OmpA are indicated. Lanes
are numbered as described above. (C) SecA ATPase activity of
urea-treated IMVs in the absence (white bars) and presence (black
bars) of proOmpA. Lanes are numbered as described above.
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and that both TMSs are in close proximity, i.e., within
disulfide bonding distance.
SecE(L106C) Contacts a Neighboring SecE Molecule. In
all samples that contained the SecE(L106C) mutant, even
in combination with the Cys-less SecY, the oxidizing
conditions also yielded a highly specific protein band with
an apparent molecular mass of 28 kDa (Figure 3). This cross-
link stained only with the pAb directed against SecE, and
not with the SecY- or SecG-specific antibodies. The 28 kDa
cross-linked product disappeared upon incubation with DTT,
and was not found with wild-type SecE. On the basis of its
size, it may represent an oxidized dimer of SecE(L106C)
molecules. To exclude cross-linking of SecE(L106C) with
another membrane protein of unknown identity, both the
SecYE(L106C)G and Cys-less SecYEG complex were puri-
fied to homogeneity (17). The SecE(L106C) molecule
copurified with SecG and the His-tagged Cys-less SecY with
the same stoichiometry as the wild-type SecYEG complex
(data not shown), which confirms that the SecE mutant
normally interacts with SecY and SecG. Moreover, under
oxidizing conditions, the reconstituted SecYE(L106C)G
complex again yielded the 28 kDa protein band (Figure 4),
while the cross-linked band was not observed with the Cys-
less SecYEG complex. This unequivocally demonstrates that
oxidation of the SecYE(L106C)G complex results in dimer-
ization of SecE. It is important to stress that the apparent
ratio between monomeric SecE and the species cross-linked
to SecY or SecE on Western blots depended on the applied
blotting conditions. Longer blotting times resulted in a loss
of signal of the polypeptide band representing monomeric
SecE, whereas shorter blotting times hardly revealed any
cross-linked SecE. Therefore, even though the amount of
SecE is equal in all samples, the total of immunostained SecE
varies. The blotting conditions applied were optimal for
visualizing the cross-linked products without complete loss
of the monomeric SecE signal. As the unique dimerization
FIGURE 3: Identification of specific cross-links between unique cysteines in TMS 2 of SecY and TMS 3 of SecE. IMVs derived from
SF100 cells overexpressing the SecYEG complex containing pairs of the indicated Cys mutants in TMS 2 of amino-terminally His-tagged
SecY and the following Cys mutants in TMS 3 of SecE: S105C (lane 1), L106C (lane 2), I107C (lane 3), L108C (lane 4), and W109C
(lane 5). IMVs were oxidized for 30 min on ice in the presence of Cu2+(phenanthroline)3, and subsequently quenched with an excess of
neocuproine. Samples were analyzed by immunoblotting using pAbs directed against SecY and SecE. Resultant cross-linked products with
apparent molecular masses of 50 (SecY-E) and 28 kDa (SecE-E) are denoted. SecY stains as a double band due to the presence of the
endogenous SecY, overexpressed His-tagged SecY, and proteolytic loss of the His tag. The protein band that appears in all samples at 30
kDa and slightly above the SecE-E cross-link is outer membrane protein A (OmpA), which is nonspecifically detected by the anti-SecE
pAb. Note that this band is not present in the oxidized purified SecYE(L106C)G complexes shown in Figure 4.
FIGURE 4: The 28 kDa cross-linked product represents a SecE
dimer. Proteoliposomes reconstituted with the purified Cys-less
SecYEG and SecYE(L106C)G complex (6.5 íg/mL) were oxidized
for 30 min on ice in the presence of Cu2+(phenanthroline)3, as
indicated, and subsequently quenched with an excess of neocu-
proine. Samples were separated on SDS-PAGE in the absence or
presence of DTT, blotted, and immunostained with pAbs directed
against SecE. The position of the 28 kDa cross-linked SecE product
is indicated (SecE-E).
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of the SecE(L106C) mutant was observed after purification
and reconstitution of the SecYE(L106C)G complex, it
unlikely results from a loose interaction with SecY or an
overstoichiometric expression level of the mutant SecE
molecule. The latter is also apparent from the overexpression
level of SecE(L106C), which is the same as for the other
SecE Cys mutants.
When each of the single Cys SecE mutants was overex-
pressed separately, i.e., without SecY and SecG, the oxida-
tion-induced formation of the 28 kDa cross-linked product
was no longer unique for the SecE(L106C) but occurred with
all constructs (Figure 5). Apparently, uncomplexed SecE is
in a conformation in which cross-linking of cysteines in TMS
3 readily occurs upon oxidation. However, upon association
with SecY, SecE is oriented in such a manner that except
for SecE(L106C), all Cys mutants are protected from
disulfide bond formation. These results therefore suggest that
SecE(L106) cross-links with another SecE molecule within
the SecYEG complex (Figure 9) as confirmed by the
experiments with the purified SecYEG (Figure 4).
Oxidation of SecYE(L106C)G Inhibits Translocation. To
establish whether the formation of the SecE(L106C) dimer
had any influence on the activity of the SecYEG complex,
Cys-less SecYEG or SecYE(L106C)G was treated with Cu2+-
(phenanthroline)3 and analyzed for SecA-dependent pro-
OmpA translocation. These studies were performed with both
IMVs (data not shown) and proteoliposomes reconstituted
with the purified SecYEG complexes (Figure 6). The level
of translocation of proOmpA with SecYE(L106C)G was
greatly reduced by oxidation, whereas the Cys-less SecYEG
allowed translocation up to a translocation intermediate (I31)
with a molecular mass of 31 kDa. The latter is due to the
presence of a disulfide bridge in the carboxyl terminus of
proOmpA that prevents further translocation (11). In IMVs,
this intermediate exhibits an apparent molecular mass of 29
kDa due to the removal of the signal peptide by leader
peptidase. Upon addition of DTT, proOmpA translocation
with Cys-less SecYEG and SecYE(L106C)G occurred at
equally effective levels (Figure 6). These results demonstrate
that the oxidation-induced dimerization of SecE(L106C)
inactivates translocase in a reversible manner. The effect of
oxidation of the SecY-SecE single-cysteine pairs was not
further analyzed due to the low efficiency of disulfide bond
formation.
Dimerized SecE(L106C) Uncouples the SecA ATPase
ActiVity. The effect of the oxidation of the SecY-bound SecE-
(L106C) was further examined by assessing the SecA
membrane binding and insertion, and the SecA translocation
ATPase activity. SecA binds with high affinity to the
SecYEG complex, and with low affinity to the membrane
lipids. The binding of 125I-labeled SecA to urea-treated IMVs
FIGURE 5: Single-Cys mutants of SecE dimerize when overexpressed in the absence of SecY. IMVs derived from SF100 cells overexpressing
SecE (wild-type, lane 1), SecE(S105C) (lane 2), SecE(L106C) (lane 3), SecE(I107C) (lane 4), SecE(L108C) (lane 5), and SecE(W109C)
(lane 6) were oxidized with Cu2+(phenanthroline)3, quenched with neocuproine, and separated on SDS-PAGE in the absence (-DTT) and
presence of DTT (+DTT). Samples were stained with Coomassie brilliant blue, and the position of the SecE dimer is indicated (SecE-E).
FIGURE 6: Proteoliposomes bearing SecYE(L106C)G are reversibly
inactivated upon oxidation. Samples containing Cys-less SecYEG
or SecYE(L106C)G proteoliposomes (6.5 íg/mL) were oxidized
for 30 min on ice with 1 mM Cu2+(phenanthroline)3, transferred
to an environment with a temperature of 37 °C, and further
incubated for 5 min in the absence or presence of 10 mM DTT.
Translocation was followed in time after the addition of [125I]-
proOmpA, SecA (10 íg/mL), and ATP (2 mM). The arrows denote
the positions of proOmpA and the translocation intermediate I31.
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that harbor overexpressed Cys-less SecYEG or SecYE-
(L106C)G was not affected by the oxidation with Cu2+-
(phenanthroline)3, but was effectively eliminated after the
addition of an excess of unlabeled SecA (Figure 7A). This
demonstrates that the dimerization of the SecY-bound SecE
does not interfere with the number of high-affinity SecA
binding sites. Next, we determined whether the SecYEG-
and precursor-stimulated SecA ATPase activity was influ-
enced by the oxidation of SecE(L106C). Surprisingly, the
amount of ATP hydrolysis by SecA in the presence of
proOmpA was identical to that observed with the Cys-less
SecYEG complex (Figure 7B). Since the oxidation of the
SecE(L106C) results in a near to complete block of trans-
location, the SecA translocation ATPase appears to be
uncoupled from translocation. Membrane insertion of SecA
was analyzed by the formation of a protease-protected 125I-
labeled 30 kDa fragment upon interaction with the nonhy-
drolyzable ATP analogue AMP-PNP in the presence of urea-
treated IMVs bearing Cys-less SecYEG or SecYE(L016C)G
(Figure 7C). Under reducing conditions, both the Cys-less
SecYEG and SecYE(L106C)G complex allowed formation
of the proteolytic 30 kDa SecA fragment. Oxidizing condi-
tions strongly, but not completely, inhibited 30 kDa formation
with the SecYE(L106C)G complex. These data demonstrate
that SecA retains the ability to bind with high affinity to the
oxidized SecYE(L106C)G complex and to hydrolyze ATP.
Since membrane insertion is not completely prevented under
oxidizing conditions, it cannot be excluded whether the
remaining membrane insertion activity relates to incomplete
oxidation of SecE(L106C) or residual activity of the oxidized
SecYE(L106C)G channel. We conclude, however, that the
oxidized SecYE(L106C)G channel must be in a close-to-
functional state to allow SecA binding and an uncoupled
translocation ATPase activity.
SecA Modulates the Intrahelical Contact between Neigh-
boring SecE Molecules. To examine whether the formation
of the Sec(L106C) dimer was modulated by translocation
conditions, conditions that abolished dimer formation were
explored. When urea-treated membrane vesicles bearing
SecYE(L106C)G were extensively prereduced with 5 mM
DTT, diluted in buffer without DTT, and subsequently
oxidized by the addition of Cu2+(phenanthroline)3, only a
low level of SecE(L106C) dimer was formed (Figure 8, lane
2). We used this method of prereduction as an assay to
determine conditions that modulate the efficiency of dimer
formation, and in this manner to detect dynamic changes in
the subunit interactions of SecYEG during translocation. The
yield of dimer formation was not affected by the addition of
SecA irrespective of the presence or absence of proOmpA
(lanes 4 and 3, respectively) or by the subsequent addition
of ATP (lane 5). However, a dramatic elevation of the level
of SecE dimer formation occurred when instead of ATP, the
nonhydrolyzable ATP analogue AMP-PNP was added to the
solution (lane 6). This phenomenon strictly depended on the
presence of the preprotein, since in the absence of proOmpA,
no stimulation of dimer formation was observed (lane 7).
We then tested whether other conditions leading to the stable
insertion of SecA had an effect on the SecE(L106C) cross-
linking. Indeed, a preprotein-dependent stimulation was
observed when ATP-ç-S was used as a nonhydrolyzable ATP
analogue (lanes 8 and 9). Nonhydrolyzable ATP analogues
block translocation in its initial stage, leading to the
processing of the signal sequence by leader peptidase (11)
and a stabilization of the SecA membrane-inserted state (10).
To block SecA in its membrane-inserted state during later
stages of the translocation reaction, the ATPase inhibitor
azide was added 25 min after the addition of ATP (lane 11).
Azide interferes with the SecA ATPase activity (47), but
FIGURE 7: Dimerized SecE(L106C) binds SecA with high affinity
and does not inhibit membrane insertion, but uncouples the
translocation ATPase activity (A) SecA binding. Reduced or
oxidized IMVs (50 íg/mL) bearing overexpressed SecYE(L106C)G
or Cys-less SecYEG were incubated for 15 min on ice in the
presence of 30 nM 125I-labeled SecA. The extent of binding of SecA
to the vesicles was determined after their isolation through a 0.2
M sucrose cushion (white bars). The nonspecific binding level was
determined in the presence of 500 nM unlabeled SecA (black bars).
Error bars represent the mean standard error of three independent
experiments. (B) SecA ATPase activity in the presence (white bars)
or absence (black bars) of proOmpA. Averages and deviations of
two experiments are shown. (C) SecA membrane insertion. The
extent of the AMP-PNP-induced membrane insertion of SecA was
measured as the level of formation of a 30 kDa 125I-labeled
proteolytic SecA fragment in the presence of reduced (+DTT) or
oxidized [+Cu2+(phenanthroline)3] IMVs bearing overproduced
Cys-less SecYEG (lanes 1-3) or SecYE(L106C)G (lanes 4-6).
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enforces the formation of membrane-inserted SecA by
preventing its deinsertion (41). This effect appears to be
strongest during an ongoing translocation reaction (lane 11),
as the addition of azide before initiation of translocation with
ATP did not result in an increased level of SecE(L106C)
dimerization (lane 10). Also in the case of the azide-induced
SecA membrane insertion, the effect on the SecE cross-
linking was dependent on the presence of preprotein (lane
12). Under the same set of conditions, we were unable to
detect a change in the yield of the SecY-SecE cross-link
using the SecY(A79C) and SecE(L108C) mutant pair (data
not shown). Furthermore, none of the other SecE Cys mutants
exhibited dimer formation under the conditions described
above. These results demonstrate that translocase undergoes
dynamic changes that influence the proximity of two SecY-
bound SecE molecules. This phenomenon is coupled to the
membrane insertion of SecA and takes place only with active
translocase, i.e., in the presence of preprotein.
DISCUSSION
In this paper, we provide direct evidence for an interaction
between TMS 2 of SecY and TMS 3 of SecE of E. coli, and
demonstrate that the SecYG-bound SecE interacts with a
neighboring SecE molecule. SecA influences the latter
interaction in a preprotein- and nucleotide-dependent manner.
For this study, we have used a Cys-less SecYEG complex
to allow cysteine scanning mutagenesis. The two endogenous
Cys residues of SecY were replaced with serine residues,
yielding a fully functional SecYEG complex that was
subsequently used to introduce unique Cys residues into TMS
2 of SecY (F78-I82) and TMS 3 of SecE (S105-W109).
These helical regions were chosen on the basis of the
genetically identified interaction between periplasmic loop
1 (P1) of SecY and P2 of SecE (30). All mutants could be
functionally overexpressed, implying that the SecY-SecE
interaction in these mutants is retained as the stability of
SecY in the cell is dependent on its interaction with SecE
(46). None of the cysteine mutants exhibited a strong prl
phenotype, as evidenced by the inability of these highly
overexpressed mutants to translocate ¢8proOmpA, despite
the fact that one of the mutated residues SecE(L108) was
previously shown to yield a prlG suppressor phenotype when
substituted for an arginine (35).
By means of Cu2+(phenanthroline)3-induced disulfide bond
formation, an interaction could be demonstrated between
cysteines replacing F78 and A79 in TMS 2 of SecY and
L108 in TMS 3 of SecE. These residues are restricted to a
specific helical face of both TMSs, and strikingly, cross-
linking reappeared when the Cys mutations were moved a
single R-helical turn, replacing I82 in SecY and S105 in SecE
(Figure 9). L108 in TMS 3 of SecE was found to make
disulfide bonds with two adjacent positions in TMS 2 of
SecY, suggesting some conformational flexibility in this
region or in the side chains of the introduced Cys residues.
FIGURE 8: Stable membrane insertion of SecA promotes interhelical SecE(L106C) contacts. IMVs containing overproduced SecYE(L106C)G
were prereduced with 5 mM DTT and diluted into translocation mixtures containing SecA, proOmpA (pOA), 2 mM ATP, AMP-PNP, or
ATPçS, as indicated. NaN3 (20 mM) was added either before the onset of the translocation reaction (lane 10) or after translocation for 25
min (lanes 11 and 12). After 30 min, samples (lanes 2-12) were oxidized by further incubation for 30 min on ice in the presence of 1 mM
Cu2+(phenanthroline)3. Lane 1 corresponds to the reduced control.
FIGURE 9: Schematic representation showing the periodic sites of
interaction between TMS 2 of SecY and TMS 3 of SecE, and the
identified site of interaction between TMS 3 of neighboring SecE
molecules. In black are denoted the mutagenized amino acids
residues that are part of the amino acid sequences of residues 77-
85 and 102-110 of SecY and SecE, respectively. For simplicity,
the SecY interaction for the second SecE molecule is not shown.
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Previous genetic evidence suggested an interaction between
P1 of SecY and P2 of SecE, and we now show that this
interaction reflects a close proximity between at least two
of the associated transmembrane helices. Interactions of SecY
cytoplasmic loop 4 (C4) together with SecE C2 and of TMS
7 and TMS 10 of SecY together with TMS 3 of SecE have
been identified genetically (30-32). TMS 2, 7, and 10 of
SecY are the most conserved, whereas TMS 3 of SecE is
the only membrane span that is necessary for the SecE
function. Most prlA mutations of SecY that allow the
translocation of signal sequence defective preproteins are
clustered in P2, TMS 7, and TMS 10 of SecY (29, 30). TMS
3 of SecE may therefore be surrounded by the conserved
core of the integral membrane domain of the translocase,
i.e., TMS 2, TMS 7, and TMS 10 of SecY. On the basis of
a systematic cross-linking study of the linking of the signal
sequence of a preprotein to the yeast translocase, it has been
postulated that the signal sequence and Sss1p-SecE bind
to the same or overlapping regions in Sec61p-SecY (48).
The same study shows that TMS 2 and TMS 7 of Sec61p
can be cross-linked to the signal sequence. Our report extends
this postulate and demonstrates that TMS 2 of SecY is indeed
in close proximity of TMS 3 of SecE, specifying this
interaction to defined residues. Conditions that lead to the
membrane insertion of the signal sequence or that allow
preprotein translocation did, however, not affect the extent
of the Cu2+(phenanthroline)3-induced cross-linking of SecY-
(A79C) to Sec(L108C). These conditions also did not affect
the cross-linking between other SecE Cys mutants, excluding
the possibility that SecE is expelled from the translocase by
the signal sequence. These data thus suggest a stable
interaction between SecY and SecE that persists during
translocation.
One of the five examined Cys mutants of TMS 3 of SecE,
SecE(L106C), exhibits a Cu2+(phenanthroline)3-induced dimer-
ization, irrespective of its combination with the wild-type,
Cys-less, or single-Cys mutants of SecY. The other four Cys
mutants of SecE exhibited such behavior only when over-
expressed in the absence of SecY. SecE(L106C) seems to
interact with SecY in a manner that is indistinguishable from
that of the wild type, which has been shown not to dissociate
from SecY in the membrane (49). The stability of the SecY-
SecE(L106C) interaction was confirmed by purification of
the SecYE(L106C)G complex, which after reconstitution
showed the same Cu2+(phenanthroline)3-induced dimerization
of SecE. The purified SecYE(L106C)G complex provided
unequivocal evidence that the cross-linked SecE product
indeed consists of a SecE dimer that is associated with the
other translocase subunits. Although the oxidized SecYE-
(L106C)G channel binds SecA and allows it to undergo
cycles of ATP binding and hydrolysis, translocation and
SecA membrane insertion are severely impaired. Apparently,
FIGURE 10: Schematic model for the modulation of the SecYEG translocation channel by the membrane insertion of SecA. Binding of a
precursor protein activates the SecYEG-bound SecA, which triggers channel opening of an oligomeric assembly of SecYEG complexes.
Subsequent binding of ATP to SecA drives the insertion of a SecA domain together with the signal sequence and amino-terminal mature
region of the precursor protein into the translocation channel. This process is accompanied by the inversion of the SecG membrane topology
(indicated by the reversed G) and a rearrangement of the SecY-bound SecE bringing the L106C residues (represented by a black stalk) at
the periplasmic side of SecE TMS 3 in closer proximity. The latter rearrangement may be necessary to accommodate the inserted preprotein.
For simplicity, a dimeric assembly of the SecYEG complex is shown.
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this SecYEG channel is trapped in a partially functional state
that no longer is able to meet the requirements that allow
complete translocation reaction cycles.
The dynamic nature of the SecYEG channel was visualized
by the modulation of SecE(L106C) dimerization by SecA.
Membrane-inserted SecA affects the conformation of the
SecYEG protein translocation channel in such a manner that
it affects the proximity of two SecE TMS 3 helices (see the
scheme in Figure 10). This was apparent, as stabilization of
the membrane-inserted state of SecA by nonhydrolyzable
ATP analogues or azide caused a marked stimulation of the
Cu2+(phenanthroline)3-induced dimerization of SecE(L106C).
As both SecE molecules are part of the SecYEG complex,
this event may reflect conformational changes within an
oligomeric organization of multiple SecYEG heterotrimers
that together form a translocation channel. Such an oligo-
meric organization of the protein-conducting channel has
been demonstrated by electron microscopy for the homo-
logues eukaryotic Sec61p and the B. subtilis SecYE complex.
In addition, the oligomeric organization of the SecYEG
complex explains the paradigm that SecY and SecE do not
dissociate in vivo (49) but appear to interact dynamically
(50). Our experiments are consistent with an oligomeric
assembly of the SecYEG complex where two SecE molecules
are in close proximity, but do not reveal the exact stoichi-
ometry of such a complex. As the sites of interactions
between SecY and SecE are restricted to specific regions of
the two molecules (refs 30-32 and this study), it is most
likely that they interact in a stoichiometric fashion. This is
also apparent from their interdependent expression and
cellular expression levels (46, 51). We therefore propose that
the observed SecE-E interaction takes place between two
SecYEG subunits within the oligomeric channel.
The modulation of the SecE(L106C) dimerization by SecA
strictly required the presence of proOmpA, although SecA
membrane insertion with AMP-PNP is precursor-independent
(10). We therefore postulate that interrelated but separate
events underlie the modulation of the translocation channel
by preproteins and SecA. First, signal sequence recognition
triggers a conformational change in the SecYEG channel and
thereby activates or “opens” the translocation channel (Figure
10, channel opening). Such a phenomenon has been postu-
lated for both SecYEG (52) and the Sec61p protein-
conducting channel (53). Whereas the pore size of the Sec61
channel upon interaction with the ribosome is around 2 nm
(26, 27), it is opened to 4-6 nm in the presence of ribosome-
nascent chain complexes (54). In the E. coli system, the
signal sequence recognition may involve a specific confor-
mational state of SecA that triggers opening of the SecYEG
channel. Second, the active protein translocation channel
undergoes conformational changes during the translocation
reaction that are elicited through cycles of conformational
changes that take place in the SecA molecule. Only with
the precursor-activated translocation channel does SecA
membrane insertion trigger the intimate contact between two
SecE(L106C) molecules that causes disulfide bond formation
(Figure 10, membrane insertion). We propose that SecA
membrane insertion results in a subunit rearrangement or a
conformational change of the active SecYEG translocation
channel that brings the L106C residues in SecE in a position
favorable for disulfide bond formation (Figure 10).
The modulation of the cross-linking of SecE(L106C)
together with the SecG topology inversion (55) and SecA
cycling at the cytoplasmic membrane (10) demonstrate that
translocase is a highly dynamic protein complex, and indicate
a strong relationship between the conformation of SecA and
that of the SecYEG complex. The identified contacts between
TMS 2 of SecY and TMS 3 of SecE (Figure 9) can be
incorporated into a model of the molecular architecture of
the SecYEG complex that will serve as a starting point for
identifying further inter- and intramolecular interactions for
obtaining a low-resolution molecular model of the integral
membrane domain of the translocase.
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